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Introduction: Variants in genes encoding for HIV-1 co-receptors and their natural ligands have been 
individually associated to natural resistance to HIV-1 infection. However, the simultaneous presence of 
these variants has been poorly studied.
Objective: To evaluate the association of single and multilocus haplotypes in genes coding for the viral 
co-receptors CCR5 and CCR2, and their ligands CCL3 and CCL5, with resistance or susceptibility to 
HIV-1 infection.
Materials and methods: Nine variants in CCR5-CCR2, two SNPs in CCL3 and two in CCL5 were 
genotyped by PCR-RFLP in 35 seropositive (cases) and 49 HIV-1-exposed seronegative Colombian 
individuals (controls). Haplotypes were inferred using the Arlequin software, and their frequency in 
individual or combined loci was compared between cases and controls by the chi-square test. A p’ value 
<0.05 after Bonferroni correction was considered significant.
Results: Homozygosis of the human haplogroup (HH) E was absent in controls and frequent in cases, 
showing a tendency to susceptibility. The haplotypes C-C and T-T in CCL3 were associated with 
susceptibility (p’=0.016) and resistance (p’<0.0001) to HIV-1 infection, respectively. Finally, in multilocus 
analysis, the haplotype combinations formed by HHC in CCR5-CCR2, T-T in CCL3 and G-C in CCL5 
were associated with resistance (p’=0.006).
Conclusion: Our results suggest that specific combinations of variants in genes from the same signaling 
pathway can define an HIV-1 resistant phenotype. Despite our small sample size, our statistically 
significant associations suggest strong effects; however, these results should be further validated in 
larger cohorts.
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Los haplotipos en CCR5-CCR2, CCL3 y CCL5 se asocian con resistencia natural a la infección 
por el HIV-1 en una cohorte colombiana
Introducción. Algunas variantes en genes que codifican los correceptores del HIV-1 y sus ligandos 
se han asociado individualmente a la resistencia natural frente a dicha infección. Sin embargo, su 
presencia simultánea ha sido poco estudiada.
Objetivo. Evaluar la asociación de haplotipos individuales y multilocus en genes que codifican los 
correceptores virales CCR5 y CCR2 y sus ligandos CCL3 y CCL5 con la resistencia o la propensión a 
la infección por el HIV-1.
Materiales y métodos. Nueve variantes en CCR5-CCR2, dos en CCL3 y dos en CCL5 fueron 
genotipificadas mediante reacción en cadena de la polimerasa de polimorfismos de longitud de 
fragmentos de restricción (Restriction Fragment Length Polymorphism-PCR-RFLP) en 35 individuos 
seropositivos (casos) y 49 seronegativos expuestos (controles) de Colombia. Los haplotipos se infirieron 
utilizando el programa Arlequín, y su frecuencia individual o combinada se comparó en los casos y los 
controles mediante la prueba de ji al cuadrado. Se consideró significativo un valor de p’<0,05 después 
de la corrección de Bonferroni.
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Resultados. La homocigosis del haplogrupo humano (HH) E estaba ausente en los controles y era 
frecuente en los casos, es decir, con tendencia hacia la propensión. Los haplotipos C-C y T-T en CCL3 
se asociaron con la propensión (p’=0,016) y la resistencia (p’<0,0001), respectivamente. Por último, en 
el análisis multilocus, el haplotipo combinado formado por HHC en CCR5-CCR2, T-T en CCL3 y G-C 
en CCL5 se asoció con la resistencia (p’=0,006).
Conclusión. Los resultados de este estudio sugieren que ciertas combinaciones específicas de variantes 
en los genes de una misma vía de señalización pueden definir un fenotipo resistente al HIV-1. Aunque el 
tamaño de la muestra era pequeño, las asociaciones estadísticamente significativas sugieren un efecto 
considerable; sin embargo, estos resultados deben validarse en cohortes de mayor tamaño.
Palabras clave: HIV-1, inmunidad innata; fenotipo; haplotipos; Colombia.
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Natural resistance to HIV-1 infection exhibited by 
some individuals who, despite being in direct contact 
with the virus, show no evidence of infection (known 
as HIV-1-exposed seronegative, HESN) has been 
associated, among others, to polymorphisms in 
genes that encode the HIV-1 co-receptors CCR5 
and CXCR4, as well as the alternative co-receptor 
CCR2 (1). 
Seven major haplotypes have been described 
based on unique combinations of polymorphic sites 
in CCR5 and the adjacent CCR2 gene, which were 
phylogenetically established and named as human 
haplogroups (HH) A, B, C, D, E, F (F1, F2) and G 
(G1, G2)(2,3). Some of these have been associated 
with either resistance (HHG2, HHA, HHF2) (2,4,5) 
or increased susceptibility to HIV-1 infection and 
accelerated AIDS progression (HHE) (6-8). Further-
more, polymorphisms located in promoter or intronic 
regions of the natural ligands of CCR5, CCL3 (also 
known as MIP-1α, encoded by CCL3) and CCL5 
(also known as RANTES, encoded by CCL5) could 
modify the secretion levels of these peptides further 
influencing the resistance or susceptibility (R/S) to 
HIV-1 infection by competition with the CCR5 co-
receptor (3). 
In this study, we determined the association of 
multilocus haplotypes formed by variants on the 
promoter and coding regions of the CCR5-CCR2 
locus, and the CCL3 and CCL5 genes with R/S to 
HIV-1 infection in a cohort of serodiscordant couples 
from Colombia.
Materials and methods
Study group
Samples were taken from a cohort of serodiscordant 
couples previously recruited at the Hospital San 
Vicente Fundación in Medellín that included 49 
(17 men, 32 women) HESNs and 35 (31 men, four 
women) seropositive (SP) individuals.The selection 
criteria for HESNs were previously described (9) as 
absence of anti-p24 antibodies during at least six 
months of follow-up, in which at least two sexual 
intercourses occurred per week with an HIV-1 
positive individual. For all cases, the HIV-1 status 
was tested by ELISA (Abbot Axsym System) and 
confirmed through western blot (NewLab blot) 
following the manufacturer’s instructions. 
This study was approved by the bioethics board 
of the Universidad de Antioquia’s Instituto de 
Investigaciones Médicas and all participants signed 
an informed consent.
Genotype analysis
DNA was obtained from peripheral blood using the 
phenol-chlorophorm method. The genotyping of 
the 32-base-pair deletion (Δ32, rs333) on CCR5 
was performed by conventional PCR as previously 
described (9). The identification of SNPs in the 
selected genes (-2733A>G [rs2856758], -2554G>T 
[rs2734648], -2459G>A [rs1799987], -2135T>C 
[rs1799988], -2132C>T [rs41469351], -2086A>G 
[rs1800023] and -1835C>T [rs1800024] in CCR5; 
190G>A [64Val>Ile, rs1799864] in CCR2; 73+40C 
>T [rs35511254] and 74-333C>T [rs111235874] 
in CCL3; -403G>A [rs2107538] and -28C>G 
[rs2280788] in CCL5) was performed by PCR-RFLP 
using the oligonucleotides, restriction enzymes 
and protocols previously reported by González, 
et al. (2,3). PCR reactions were performed on 25 
µl final mix containing 2.5 µl 10X reaction buffer 
(Thermo Scientific, St. Leon-Rot, Germany), 0.2 
µl recombinant Taq polymerase 5 IU/µl (Thermo 
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Scientific), 1 µl primers 25 mM and 2 µl DNA 8 µg/
ml. Endonuclease digestion was performed on 13 
µl of amplification products with 0.2 µl restriction 
endonucleases 10 IU/µl (Thermo Scientific) and 1.5 
µl 10X reaction buffer (Thermo Scientific) following 
the protocols reported by González, et al. (2,3). PCR 
and endonuclease digestion products were checked 
on 1.5% and 2.5% agarose gels, respectively.
Statistical analysis
Hardy-Weinberg equilibrium and genotype and allele 
frequencies were calculated using the GENPOP 
software, v. 3.4 (10). Most probable haplotypes were 
generated through a maximum likelihood test using 
the Arlequin software, v. 3.5(11) and haplogroups 
were defined according to previous reports (2,5). 
The DnaSP software v.5 (12) was used to calculate 
linkage disequilibrium and haplotype frequencies. 
All comparisons were performed in the Graphpad 
Prism 6.05 software using either the chi-square or 
the Fisher exact test, both with Bonferroni correction 
for multiple comparisons (referred to as p’), based on 
the number of principal haplotypes (with a frequency 
>0.05) as previously described (13). A corrected p’ 
value (p x number of comparisons per group) <0.05 
was considered statistically significant.
Results
Demographic data
In this study we included samples from 49 HESN 
and 35 SP individuals of a previously defined cohort 
of serodiscordant couples (including heterosexual 
and homosexual couples, as well as SP individuals 
with more than one HESN sexual partner). In our 
samples, 17 males and 32 females corresponded to 
the HESN group, whereas 31 males and four females 
corresponded to the SP group. The mean age was 35 
and 31 years for HESN and SP, respectively. The time 
of HIV-1 exposure among HESN individuals ranged 
between six months and four years. No genetic 
structure between cases and controls was expected, 
as the population was recruited in Medellín, whose 
population has been previously demonstrated to be 
homogeneous given its history of isolation (14,15).
Haplotype distribution
The selected loci on CCR5 and CCR2 successfully 
genotyped in all individuals of our cohort. These 
variants were successfully grouped within the nine 
previously reported HHs. Of all HHs, only HHB was 
not found in this study. In total, we found 21 out of 
36 expected haplogroup pairs (binomial coefficient 
C(8,2)), with the presence of 14 and 17 pairs in the 
SP and HESN groups, respectively, C/E being the 
most frequent in both groups (0.257 for SPs and 
0.265 for HESNs) (table 1).
For the two polymorphic sites of CCL3, only 18 and 
21 samples successfully amplified both SNPs in 
HESNs and SPs, respectively. For these, the four 
possible haplotypes (2 loci x 2 variants in each) 
and seven out of ten expected haplotype pairs 
(C(4,2)) were observed in total, with four and five 
pairs in the SP and HESN groups, respectively. 
For the two polymorphic sites in CCL5, only 14 and 
19 samples successfully amplified both SNPs in 
HESNs and SPs, respectively. For these, the four 
possible haplotypes and five out of ten expected 
haplotype pairs were observed in total, with four 
and five pairs found in the SP and HESN groups, 
respectively (table1).
To determine the combined association of variants 
in HHs, CCL5 and CCL3 with R/S, a multilocus 
analysis was performed. Nonetheless, we could 
only use 14 samples in HESNs and 19 in SPs that 
successfully amplified and enzyme-digested the 13 
tested loci. For this multilocus combination of HH, 
CCL3 and CCL5, we found 26 haplotypes and 22 
haplotype pairs in total, with ten haplotypes and 12 
pairs in HESNs and 16 haplotypes and 15 pairs in 
SPs, out of 128 expected haplotypes (8HH x 4CCL3 x 
4CCL3) and 805 expected pairs (23HH x 7CCL3 x 5CCL5) 
(table 2).
Association analysis
Whereas none of the HHs were individually 
associated with R/S to HIV-1 infection, homo-
zygosis of HHE (E/E) was only found in infected 
individuals, showing a non-significant tendency 
towards susceptibility (p=0.069, p’>1). For CCL3, 
the haplotype C-C was higher in SPs (p=0.004, 
p’=0.016) while haplotype T-T was higher in 
HESNs (p<0.0001, p’<0.0001). When paired, the 
combination CT-CC was associated with suscep-
tibility (p=0.035, p’=0.245), whereas CT-TT was 
associated with resistance (p=0.002, p’=0.014). 
For CCL5, no significant differences were found 
for either haplotypes or pairs of haplotypes. 
After multilocus analysis we observed that the 
simultaneous presence of HHC with T-T in CCL3 
and G-C in CCL5 was strongly associated with 
resistance to infection (p=0.0005, p’=0.006), and so 
was the paired combination of HHC/F2 with TT-TT 
in CCL3 and AG-CC in CCL5; however, this latter 
situation did not remain significant after Bonferroni 
correction (p=0.040, p’=0.880). These results are 
summarized in table 3.
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Discussion
An important component involved in the R/S to 
HIV-1 infection is the expression levels of the 
CCR5 co-receptor on the cell. Previous studies 
have shown that several members of the NF-
κB and c-Rel families have different binding 
and affinity across the CCR5 promoter region 
depending of both single SNPs and whole CCR5 
HH, which regulate in different ways the mRNA 
levels, translation capacity and, ultimately, protein 
expression (16). Indeed, previous findings have 
shown that HHE has a higher promoter activity than 
the ancestral and protective HHA, as measured by 
the luciferase activity test (17,18), leading to higher 
expression of CCR5 in individuals carrying HHE. 
Although not significant after Bonferroni correction, 
probably due to our small sample size, our finding 
concerning HH E/E pointing towards suscep-
tibility to HIV-1 infection is in concordance with 
previous studies showing an association with 
seroconversion and progression to AIDS (2,7,19), 
and could be explained by the expected higher 
expression of CCR5. An interesting point is that 
the susceptibility-associated effect of the HHE 
Table 1. Frequencies obtained for single locus analyses. Left columns indicate the frequency of the single copy of a given haplotype, 
whereas the right columns indicate the frequency of paired haplotypes. Haplotypes marked in bold reached statistical significance 
before Bonferroni correction.
 Single haplotype copy Freq. in SP Freq. in HESN Paired haplotype Freq. in SP Freq. in HESN
HH n=35 n=49 n=35 n=49
A 0.014 0.020 A/C 0.028 0.021
B 0.000 0.000 A/E 0.000 0.021
C 0.243 0.337 C/C 0.028 0.062
D 0.071 0.020 C/D 0.057 0.000
E 0.314 0.245 C/E 0.257 0.265
F1 0.000 0.020 C/F2 0.057 0.164
F2 0.243 0.235 C/G1 0.000 0.041
G1 0.086 0.071 C/G2 0.028 0.041
G2 0.023 0.051 D/E 0.000 0.021
D/F2 0.086 0.021
E/E 0.086 0.000
E/F1 0.000 0.021
E/F2 0.143 0.122
E/G1 0.057 0.041
F1/F2 0.000 0.021
F2/F2 0.057 0.062
F2/G1 0.057 0.021
F2/G2 0.028 0.000
G1/G1 0.028 0.000
G1/G2 0.000 0.021
G2/G2 0.000 0.021
CCL3 n=21 n=18 n=21 n=18
73+40
C>T
74-333
C>T
  73+40
C>T
74-333
C>T
C C 0.476 0.172 CT CC 0.619 0.278
C T 0.143 0.217 TT TT 0.000 0.167
T C 0.381 0.217 CT TT 0.000 0.389
T T 0.000 0.394 CT CT 0.143 0.111
TT CC 0.000 0.056
CC CT 0.143 0.000
CC CC 0.095 0.000
CCL5 n=19 n=14 N=19 N=14
-403
A>G 
-28
C>G
  -403
A>G 
-28
C>G
A C 0.132 0.286 AG CC 0.211 0.500
A G 0.079 0.071 AG GG 0.000 0.071
G C 0.658 0.571 AG GC 0.211 0.143
G G 0.132 0.071 GG CG 0.211 0.071
GG CC 0.368 0.214
HH: human haplogroup; CCL3: C-C motif ligand 3; CCL5: C-C motif ligand 5; SP: HIV-1 seropositive; HESN: HIV-1 exposed seronegative
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has also been reported when paired with HHG2, 
leading to increased viral production in vitro, even 
though the latter carries the Δ32 mutation, possibly 
due to restitution of the normal CCR5 levels over 
the cell membrane (20). Nevertheless, HHG2 has 
been effectively associated with protection and 
Table 2. Frequencies obtained for multilocus haplotype analyses.  Left columns indicate the frequency of the single copy of a given 
multilocus haplotype, whereas right columns indicate the frequency of paired multilocus haplotypes. Haplotypes marked in bold 
reached statistical significance before Bonferroni correction.
Single haplotype copy Freq. 
in SP
Freq. in 
HESN
Paired haplotype Freq.
in SP
Freq. in
HESN
HH CCL3 CCL5 n=19 n=14 HH CCL3 CCL5 n=19 n=14
73+40
C>T
74-333
C>T
-403
A>G 
-28
C>G
73+40
C>T
74-333
C>T
-403
A>G 
-28
C>G
A C T G C 0.029 0.000 C/F2 CT CT AG CC 0.053 0.067
C T C A C 0.002 0.000 C/F2 TT TT AG CC 0.000 0.268
C C C G C 0.061 0.115 C/E CT CC GG CC 0.158 0.067
C T C G C 0.114 0.000 C/E CT TT AG GC 0.000 0.067
D T C G C 0.029 0.000 C/E CT TT GG CC 0.000 0.067
E T T A C 0.029 0.000 C/F2 CT CT AG GC 0.000 0.067
E T C A G 0.088 0.000 G1/G2 CT CC GG GC 0.000 0.067
E T T A G 0.029 0.000 E/F2 CT CC AG GC 0.158 0.067
E C C G C 0.147 0.000 C/C CT TT AG CC 0.000 0.200
E C T G G 0.029 0.000 C/C CT CT GG CC 0.000 0.067
F2 C C A C 0.057 0.000 C/F2 CT CC GG CC 0.053 0.000
F2 C C G C 0.235 0.000 G1/G1 CC CT AG CC 0.053 0.000
F2 T C G C 0.031 0.000 F2/F2 CC CC AG CC 0.053 0.000
G1 C T A C 0.029 0.000 F2/G1 CC CC GG CC 0.053 0.000
G1 C C G C 0.059 0.038 E/E CT CT AG GC 0.053 0.000
G1 T C G G 0.029 0.000 E/G1 CT CC GG GC 0.053 0.000
C C T A C 0.000 0.077 C/E CT CC AG GC 0.053 0.000
C C T A G 0.000 0.038 F2/F2 CT CC GG CC 0.053 0.000
C T T G C 0.000 0.308 D/F2 CT CC GG CC 0.053 0.000
E C T G C 0.000 0.038 E/E CT CT AG CC 0.053 0.000
E T C G C 0.000 0.077 A/C CC CT GG CC 0.053 0.000
E T T G G 0.000 0.038 E/F2 CC CT GG GC 0.053 0.000
F2 T C A C 0.000 0.038
F2 T T A C 0.000 0.115
F2 C C A G 0.000 0.077
G2 T C G G 0.000 0.038
HH: human haplogroup; CCL3: C-C motif ligand 3; CCL5: C-C motif ligand 5; SP: HIV-1 seropositive; HESN: HIV-1 exposed seronegative
Table 3. Summary of single and multilocus haplotypes and pairs of haplotypes that reached statistical significance, both before and after 
Bonferroni correction. Frequencies in bold show the associated group, thus indicating susceptibility or resistance towards infection.
Frequency p-value p’-value
SP HESN
CCL3
73+40C>T 74-333C>T
T T 0.000 0.394 < 0.0001 <0.0001
C C 0.476 0.172 0.004 0.016
CT TT 0.000 0.111 0.002 0.014
CT CC 0.619 0.278 0.035 0.245
HH CCL3 CCL5
73+40C>T 74-333C>T -403A>G -28C>G
C T T G C 0.000 0.308   0.0005 0.006
C/F2 TT TT AG CC 0.000 0.231 0.040 0.880
SP: HIV-1 seropositive; HESN: HIV-1 exposed seronegative; HH: human haplogroup; CCL3: C-C motif ligand 3; CCL5: C-C motif ligand 5
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decreased seroconversion when found in the homo-
zygous state, or when paired with either HHA or 
HHF2 (19). These findings suggest that for HHs, 
the association with R/S depends on the effect of 
both copies carried by an individual over the overall 
expression of CCR5 on the cell membrane.
Our results regarding CCL3, where the T-T haplo-
type was associated with resistance and C-C with 
increased risk, contrast with previous reports where 
the presence of both C-C and T-T haplotypes were 
associated with resistance in Africans, whereas the 
absence of haplotype C-C in European Americans 
was associated to AIDS progression (3). Different 
ancestral backgrounds might be affecting how these 
variants synergize during exposure and infection. 
This becomes important since the Colombian popu-
lation originated through admixture processes of 
Amerindian, European and African populations (14); 
therefore, a new genetic background might explain 
these results.
Even though we did not find an association in CCL5 
alone, as was previously reported (3), we did find 
an interesting association when variants in CCR5/
CCR2, CCL3 and CCL5 were analyzed together, 
with the multilocus haplotype formed by HHC, T-T 
in CCL3 and G-C in CCL5 associated with resist-
ance. Although two meta-analyses (21,22), with 
only one single variant in CCL5 analyzed, have 
reported no association of any of them with R/S, 
our findings suggest that the simultaneous presence 
of variants on different genes involved in a common 
signaling or metabolic pathway (receptor and its 
ligands, in our case) can lead to a certain resist-
ant or susceptible phenotype, probably due to 
the synergistic effect of these variants. We thus 
hypothesize that the resistance to viral infection in 
these cases might be due to the low expression of 
the viral specific co-receptors and high levels of their 
natural ligands competing for its use, and vice-versa, 
in the susceptible phenotype. However, as reviewed 
recently (23), functional studies are required to vali-
date the function of intronic and promoter variants in 
CCL3 and CCL5 mRNA levels and stability and of 
the secretion of MIP-1α and RANTES, as no data 
concerning these effects is available.
Despite the small sample size, mainly because of 
the exploratory characteristics of this study, the 
statistically significant results obtained here, even 
after the correction for multiple comparisons, support 
the accuracy of our results and suggest strong 
effects. Careful observations should, however, be 
considered, especially since the sample size of the 
CCL3, CCL5 and multilocus analyses fell short due 
to poor amplification products. Finally, to increase 
the strength of this study, our results should be 
validated in larger cohorts.
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